Document Detail

Fetal Laboratory Medicine: On the Frontier of Maternal-Fetal Medicine.
MedLine Citation:
PMID:  22205694     Owner:  NLM     Status:  Publisher    
BACKGROUND:Emerging antenatal interventions and care delivery to the fetus require diagnostic support, including laboratory technologies, appropriate methodologies, establishment of special algorithms, and interpretative guidelines for clinical decision-making.CONTENT:Fetal diagnostic(1) and therapeutic interventions vary in invasiveness and are associated with a spectrum of risks and benefits. Fetal laboratory assessments are well served by miniaturized diagnostic methods for blood analysis. Expedited turnaround times are mandatory to support invasive interventions such as cordocentesis and intrauterine transfusions. Health-associated reference intervals are required for fetal test interpretation. Normative fetal data obtained from negative fetal cordocenteses can be confirmed by physical examination results that confirm the health of neonates whose fetal data were collected. Strategies for assurance of sample integrity from cordocenteses and confirmation of fetal origin are described. After birth, definitive assessment of prenatal environmental and/or drug exposures to the fetus can be retrospectively assessed by analysis of meconium, hair, and other alternative matrices. A rapidly advancing technology for fetal assessment is the use of fetal laboratory diagnostic techniques that use cell free fetal DNA collected from maternal plasma.SUMMARY:Developmental changes in fetal biochemical and hematologic parameters in health and disease are continually delineated by analysis of our collective outcome-based experience. Noninvasive technologies for fetal evaluation are realizing the promise of lower risk yet robust diagnostics; examples include sampling free fetal DNA from maternal blood, and analysis of fetal products accessible at maternal sites. Application of diagnostic technologies for nonmedical purposes (e.g., sex selection) underscores the importance of ethical guidelines for new technology implementation.
Sharon M Geaghan
Related Documents :
7170924 - Detection of the small-for-gestational age twin fetus by a two-stage ultrasound examina...
11444364 - Three-dimensional measurement of gestational and yolk sac volumes as predictors of preg...
22255924 - Telefetalcare: a first prototype of a wearable fetal electrocardiograph.
25468924 - Thyroid and iodine nutritional status: a uk perspective.
8695984 - Congenital chloride diarrhoea: a prenatal differential diagnosis of small bowel atresia.
8261074 - Relationship between birth weight and umbilical doppler blood flow velocity waveforms d...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-28
Journal Detail:
Title:  Clinical chemistry     Volume:  -     ISSN:  1530-8561     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421549     Medline TA:  Clin Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Pathology, Stanford University School of Medicine, Palo Alto, California.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Estimating Glomerular Filtration Rates by Use of Both Cystatin C and Standardized Serum Creatinine A...
Next Document:  Growth-Differentiation Factor-15 in the Early Diagnosis and Risk Stratification of Patients with Acu...